About Rimidi Diabetes
Rimidi Diabetes is a company based in Coral Gables (United States) founded in 2012.. Rimidi Diabetes has raised $12.84 million across 11 funding rounds from investors including Lilly, Turner Investments and Cox Enterprises. Rimidi Diabetes offers products and services including Remote Patient Monitoring and Chronic Care Management. Rimidi Diabetes operates in a competitive market with competitors including ApolloMed, Genomics, Assurecare, Patients Know Best and ZeOmega, among others.
- Headquarter Coral Gables, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.84 M (USD)
in 11 rounds
-
Latest Funding Round
$450 K (USD), Series A
Aug 15, 2025
-
Investors
Lilly
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rimidi Diabetes
Rimidi Diabetes offers a comprehensive portfolio of products and services, including Remote Patient Monitoring and Chronic Care Management. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Programs with decision support for patient monitoring and EHR integration.
Solution for improving patient outcomes and engagement through services.
Unlock access to complete
Funding Insights of Rimidi Diabetes
Rimidi Diabetes has successfully raised a total of $12.84M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $450 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series A — $450,000
-
First Round
First Round
(15 Aug 2012)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series A - Rimidi Diabetes | Valuation |
investors |
|
| May, 2025 | Amount | Series A - Rimidi Diabetes | Valuation |
investors |
|
| Jan, 2024 | Amount | Series A - Rimidi Diabetes | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rimidi Diabetes
Rimidi Diabetes has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Lilly, Turner Investments and Cox Enterprises. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Impact investments are targeted by VilCap Investments venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rimidi Diabetes
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rimidi Diabetes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rimidi Diabetes Comparisons
Competitors of Rimidi Diabetes
Rimidi Diabetes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ApolloMed, Genomics, Assurecare, Patients Know Best and ZeOmega, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health ecosystem participants are connected and provider support is integrated.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Digital population health management is provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Personal health records software is provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Population health management software is provided to payers and providers.
|
|
| domain | founded_year | HQ Location |
Provider of a DIY data science platform for health organizations to explore data and get insights
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rimidi Diabetes
Frequently Asked Questions about Rimidi Diabetes
When was Rimidi Diabetes founded?
Rimidi Diabetes was founded in 2012.
Where is Rimidi Diabetes located?
Rimidi Diabetes is headquartered in Coral Gables, United States. It is registered at Coral Gables, Florida, United States.
Is Rimidi Diabetes a funded company?
Rimidi Diabetes is a funded company, having raised a total of $12.84M across 11 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Aug 15, 2012.
What does Rimidi Diabetes do?
Cloud-based platform for diabetes management. The company has developed products like DiabetesMe, a cloud-based application that enables diabetic patients, their healthcare providers, and their care team to identify and close gaps in diabetes management, meet glucose targets, and create a more efficient cycle of care. The application leverages self-monitored glucose and lifestyle data to accurately model an individuals blood glucose profile and enable the health care provider to visualize the effects of treatment changes.
Who are the top competitors of Rimidi Diabetes?
Rimidi Diabetes's top competitors include HiLabs, Patients Know Best and Assurecare.
What products or services does Rimidi Diabetes offer?
Rimidi Diabetes offers Remote Patient Monitoring and Chronic Care Management.
Who are Rimidi Diabetes's investors?
Rimidi Diabetes has 8 investors. Key investors include Lilly, Turner Investments, Cox Enterprises, The JumpFund, and VilCap Investments.